Clinical Trial Update: A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor [Phase 2]

View source ↗

Summary

Phase II trial evaluating the combination of all-trans-retinoic acid and interferon-alpha-2a in children with recurrent neuroblastoma or Wilms tumor has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma
• Wilms Tumor

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• Interferon alpha-2a (interferon alfa-2a)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Nephroblastoma, Neuroblastoma | Phase 2 | Status: COMPLETED